Skip to content

Team

June 2022

A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants

Children with cochlear implants are at increased risk of invasive pneumococcal disease, with national and international guidelines recommending additional pneumococcal vaccines for these children. This study aimed to examine the pneumococcal immunization status and rate of invasive pneumococcal disease in children with cochlear implants at a tertiary paediatric hospital over a 12-year period.

Published research Immunisation Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Skin Health
June 2022

Blinatumomab as bridging therapy in paediatric B-cell acute lymphoblastic leukaemia complicated by invasive fungal disease

Invasive fungal disease (IFD) remains a challenging complication of treatment for paediatric acute leukaemia. Consensus fungal treatment guidelines recommend withholding chemotherapy to facilitate immune recovery in this setting, yet prolonged delays in leukaemia therapy increase risk of relapse.

Children's Cancers Published research Infectious Diseases Infectious Diseases Epidemiology Leukaemia Translational Research Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases
June 2022

Influenza vaccination among pregnant women in two hospitals in Sydney, NSW: what we can learn from women who decline vaccination

Pregnant women are recognised as being at risk of serious illness from influenza. Despite this, and longstanding national recommendations for vaccination in pregnancy, vaccine uptake remains suboptimal. This study aims to determine factors associated with women declining influenza vaccination in pregnancy.

Published research Immunisation Influenza Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases
May 2022

Antifungal use in children with acute leukaemia: state of current evidence and directions for future research

Invasive fungal disease (IFD) remains a common and serious complication in children treated for leukaemia. Antifungal prescription in children with leukaemia presents unique challenges, particularly due to variation in IFD risk between and within leukaemia treatment protocols, drug toxicities and interactions between antifungals and chemotherapeutic agents.

Children's Cancers Published research Infectious Diseases Epidemiology Leukaemia Translational Research Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases
Dr Chris Blyth

Should you get the flu vaccine in 2020?

Video

Dr Hannah Moore: On-Time Vaccination Coverage